Delivery Order SPE2DB24D1104-SPE2DB25FYDJ5
Award Date
7/16/25
Potential Completion Date
8/6/25
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $5,042.38, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of May 16, 2025....
This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $34,576.32 and is a firm fixed-price delivery order. It has an ultimate completion date of June 17, 2025. The contract is not set aside and is open to full and open...
This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGE-ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,440.70 firm fixed price delivery order was competitively awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 7, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency. The $34,576.32 firm fixed-price delivery order contract has a performance period ending on July 14, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGE/ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Medical Supply Chain. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $72,034. The contract is a delivery order with a firm fixed price and an ultimate completion date of August 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of the pharmaceutical product XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $1,800.90 firm fixed-price delivery order contract has an ultimate completion date of July 21, 2025 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is not set-aside and represents part of a larger...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $31,179.42, is for the delivery of XOLAIR 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of July 31, 2025. The contract is not set aside and was openly competed. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,881.36 delivery order contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a medical product, with a performance period through July 18, 2025. The contract is a firm fixed-price delivery order, not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,161.02, is a delivery order for the supply of XOLAIR 150 MG/ML SYRINGEML. The contract is not set aside and is a firm fixed price contract. Amerisourcebergen Drug Corp is the prime contractor and holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 17, 2025 with a ceiling value of $10,805.10. The contract has a firm fixed price and an ultimate completion date of August 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...